Related Experiment Video

Updated: Aug 29, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Upper respiratory tract carriage and transmission of pneumococci

Mahein Hussain1, Mark Clark, Amanda Tew

  • 1Institute of Child Health, London.

Nursing Times
|January 23, 2004
PubMed

Insights

Introducing a new pneumococcal conjugate vaccine requires understanding pneumococcal carriage rates. A UK study reviewed family data to assess these rates, informing public health decisions for routine immunisation schedules.

Area of Science:

  • Immunology
  • Public Health
  • Epidemiology

Background:

  • Vaccines are crucial for preventing childhood illness and death.
  • Informed decisions regarding vaccine introduction into routine schedules are essential for healthcare professionals.
  • Pneumococcal conjugate vaccines represent a significant advancement in preventing pneumococcal disease.

Purpose of the Study:

  • To evaluate the potential introduction of a novel pneumococcal conjugate vaccine.
  • To determine pneumococcal carriage rates within UK families.
  • To provide data supporting the integration of new vaccines into national immunisation programs.

Main Methods:

  • Review of a longitudinal carriage study conducted in UK families.
  • Analysis of pneumococcal carriage data over time.
  • Assessment of factors influencing pneumococcal colonisation rates.

Main Results:

  • Pneumococcal carriage rates were determined through the longitudinal study.
  • Data provides insights into the epidemiology of pneumococcus in a UK population.
  • Findings inform the potential impact and effectiveness of a new vaccine.

Conclusions:

  • Understanding pneumococcal carriage is vital for vaccine efficacy assessment.
  • The study provides essential data for the potential introduction of a new pneumococcal conjugate vaccine.
  • Evidence supports informed decision-making for routine immunisation strategies.

More Related Videos

Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.